ALLMedicine™ Achalasia Center

Dec 3rd, 2022 - Achalasia is an autoimmune disease whose probable causal agent is a neurotropic virus that chronically infects the myenteric plexus of the esophagus and induces the disease in a genetically susceptible host. The association between achalasia and c...

Dec 3rd, 2022 - Peroral endoscopic myotomy for treatment of achalasia in a patient with congenital osteogenesis imperfecta and scoliosis.|2022|Liu ZQ,Wang L,Li QL,Zhou PH,|

Dec 3rd, 2022 - Quality indicators (QIs) are formal ways to track health care performance and outcomes, guide quality improvement, and identify gaps in care delivery. We developed twelve quality indicators for achalasia management which cover the domains of patie...

Dec 2nd, 2022 - Laparoscopic hiatal hernia repair can be performed with an antireflux procedure. Routine use of an esophageal bougie has been advocated to avoid an excessively tight fundoplication. The use of an esophageal bougie carries a risk of iatrogenic comp...

Dec 2nd, 2022 - Esophagogastric junction outflow obstruction (EGJOO) is attributed to primary/idiopathic causes or secondary/mechanical causes, including hiatal hernias (HH). While patients with HH and EGJOO (HH+EGJOO) may undergo HH repair without myotomy, it is...

Feb 6th, 2022 - As many as one-half of all patients with suspected gastroesophageal reflux disease (GERD) do not derive benefit from acid suppression. This review outlines a personalized diagnostic and therapeutic approach to GERD symptoms. The Best Practice Advi...

Jul 1st, 2021 - The recommended diagnostic criteria for achalasia have been recently updated by Chicago Classification version 4.0 (CCv4.0), the widely accepted classification scheme for esophageal motility disorders using metrics from high-resolution manometry (...

Feb 11th, 2021 - Peroral endoscopic myotomy (POEM) is increasingly used as primary treatment for esophageal achalasia, in place of the options such as Heller myotomy (HM) and pneumatic dilatation (PD) OBJECTIVE: These evidence-based guidelines from the Society of ...

Aug 11th, 2020 - Achalasia is an esophageal motility disorder characterized by aberrant peristalsis and insufficient relaxation of the lower esophageal sphincter. Patients most commonly present with dysphagia to solids and liquids, regurgitation, and occasional ch...

Dec 17th, 2019 - Achalasia is a primary esophageal motor disorder of unknown etiology characterized by degeneration of the myenteric plexus, which results in impaired relaxation of the esophagogastric junction (EGJ), along with the loss of organized peristalsis in...

Oct 12th, 2022 - Per Oral Endoscopic Myotomy has been established as a safe and effective treatment of Achalasia type I and II; however, it is limited by post-procedure gastroesophageal reflux. Transoral Incisionless Fundoplication (TIF) has been introduced as the...

Sep 30th, 2022 - This is a non-randomized, non-inferiority trial that has been created to compare results of achalasia procedures including but not limited to: POEM + Partial Fundoplication (PF), POEM and Laparoscopic Modified Heller Myotomy + PF and POEM + Perora...

Sep 22nd, 2022 - Varicella zoster virus (VZV) is so well known as the cause of cutaneous varicella (chickenpox) and zoster (shingles) that it can be hard to imagine it as an enteric pathogen. VZV establishes latency during varicella and returns to the skin in zost...

Aug 16th, 2022 - Since the first published case series, per-oral endoscopic myotomy (POEM) has emerged as one of the standard treatment options for achalasia. The procedure offers a scarless endoscopic alternative to conventional surgical myotomy. In a recent rand...

Aug 15th, 2022 - • The primary outcome of the study is the incidence of significant reflux esophagitis (≥grade B) in cases with standard and extended gastric myotomies at 6 months after POEM Secondary outcomes: Significant esophageal acid exposure (>6%) as defined...

Oct 6th, 2022 - Peroral endoscopic myotomy (POEM) may be the best bet as first-line treatment for treatment-naive patients with achalasia, according to long-term trial data. POEM offered greater long-term efficacy and a low risk of treatment-related complications...

Sep 27th, 2022 - GI & Hepatology News presents the 2022 edition of Gastroenterology Data Trends (click to view the digital edition). This special issue provides updates on hot topics in gastroenterology through original infographics and visual storytelling.

Sep 19th, 2022 - Individuals with esophageal dysmotility had significantly higher scores on measures of airway reflux symptoms, based on data from 441 patients. Many patients with chronic respiratory diseases experience persistent symptoms despite optimal treatmen.

Sep 14th, 2022 - Same-day home recovery (SHR) was feasible and safe for patients who underwent elective benign foregut surgery, a prospective cohort study showed. Among 1,248 such patients participating in a Northern California healthcare system's SHR program, 11....

Sep 4th, 2022 - Approximately 30% of U. S.